Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Farmers Insurance
Mallinckrodt
Boehringer Ingelheim
Citi
McKesson
US Department of Justice
US Army

Generated: June 20, 2018

DrugPatentWatch Database Preview

DARICON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Daricon patents expire, and what generic alternatives are available?

Daricon is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in DARICON is oxyphencyclimine hydrochloride. Additional details are available on the oxyphencyclimine hydrochloride profile page.
Summary for DARICON
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 30
Patent Applications: 63
DailyMed Link:DARICON at DailyMed
Drug patent expirations by year for DARICON
Synonyms for DARICON
(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride
(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate;hydrochloride
(1,4,5,6-Tetrahydro-1-methyl-2-pyrimidinyl)methyl alpha-phenylcyclohexaneglycolate monohydrochloride
1-Methyl-1,4,5,6-tetrahydro-2-pyrimidylmethyl-alpha-cyclohexyl-phenylglycolate hydrochloride
125-52-0
125-53-1 (Parent)
21609-10-9
AC1L24JB
AKOS030526360
Benzeneacetic acid, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester, monohydrochloride
BENZENEACETIC ACID, A-CYCLOHEXYL-A-HYDROXY-,(1,4,5,6-TETRAHYDRO-1-METHYL-2-PYRIMIDINYL)METHYL ESTER, HYDROCHLORIDE (1:1)
Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester monohydrochloride
Benzeneacetic acid,a-cyclohexyl-a-hydroxy-,(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester,hydrochloride(1:1)
CAS-125-52-0
CCG-39378
CHEBI:7869
CHEMBL1200891
component of Enarax
component of Vistrax
CTK8G2233
Cyclohexaneglycolic acid, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester monohydrochloride
Cyclohexaneglycolic acid, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester, monohydrochloride
Cyclohexaneglycolic acid, alpha-phenyl-, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester, monohydrochloride
Cycmin
D01006
Daricon (TN)
Dominil
DSSTox_CID_25909
DSSTox_GSID_45909
DSSTox_RID_81220
DTXSID6045909
EINECS 204-742-8
Enterex
FT-0707726
Gastrix
HMS1922M10
HY-B0954
KB-205231
LS-56872
Manir
methyl2-cyclohexyl-2-hydroxy-2-phenyl-acetatehydrochloride
MLS000069551
MLS001074201
NCGC00018210-05
NCGC00095084-01
NCGC00095084-02
NCGC00095084-03
NSC 528449
NSC-528449
NSC-758648
NSC528449
NSC758648
Opera_ID_1394
Oximin
Oxiphencyclimine Chloride
Oxyphencyclimine (hydrochloride)
Oxyphencyclimine HCl
Oxyphencyclimine hydrochloride
Oxyphencyclimine hydrochloride (JAN)
Oxyphencyclimine hydrochloride [JAN]
Oxyphencyclimine hydrochloride [USP:JAN]
oxyphencyclimine preparation hydrochloride
Pharmakon1600-01503932
Q-201529
REGID_for_CID_66061
S 1-1236
SCHEMBL663333
Setrol
SMR000058818
Spazamin
SPECTRUM1503932
Syklifen
Tox21_111416
Tox21_111416_1
Ulcociclinina
Vagogastrin
Vio-Thene
Vistrax
W-T Anticholinergic

US Patents and Regulatory Information for DARICON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer DARICON oxyphencyclimine hydrochloride TABLET;ORAL 011612-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Farmers Insurance
Harvard Business School
US Army
AstraZeneca
Daiichi Sankyo
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.